ITMCTR1900002641
Recruiting
未知
A multi-center, randomized controlled clinical study for Xiansen Decoction combined with radiotherapy and chemotherapy in the treatment of locally advanced nasopharyngeal carcinoma
The First Affiliated Hospital of Guangzhou University of Chinese Medicine0 sitesTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- The First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Aged 18 to 75 years, male or non\-pregnant, lactating female;
- •2\. Histopathology is moderately differentiated or undifferentiated locally advanced nasopharyngeal carcinoma (WHO classification II\-III stage).
- •3\. Patients with clinical T3\-4N1M0/TxN2\-3M0 (version 8 UICC/AJCC staging) who have never received radiotherapy or cytotoxic chemotherapy (single drug or combination, except induction chemotherapy) and immunotherapy.
- •4\. ECOG:0\-1;
- •5\. Adequate bone marrow function, hematological examination: white blood cell count \>\= 4 x 10^12/ L; neutrophil count \>\= 1\.5 x 10^12 / L; platelet count \>\= 100 x 10^9 / L; hemoglobin \>\= 9g / L;
- •6\. Blood biochemical examination: normal liver function (or total bilirubin, AST, ALT \<\= 2\.5 times normal value upper limit), normal renal function (or creatinine clearance rate \>\= 60ml/min1\.5 normal value upper limit);
- •7\. The subjects volunteered to join the study and signed an informed consent form with good compliance and follow\-up.
Exclusion Criteria
- •1\. Received radiotherapy, chemotherapy or other antineoplastic therapy before the start of the clinical trial; (except induction chemotherapy).
- •2\. Those who have or are suffering from other tumors whose primary location or histology are different from those evaluated in this study. Excluding cervical carcinoma in situ, cured basal cell carcinoma, bladder surface tumor \[Ta,Tis\&T1], or any cured tumors enrolled in any distance for more than 3 years.
- •3\. Patients who have or are suffering from serious oral or salivary gland diseases.
- •4\. Patients are unwilling to stop smoking, drinking and chewing betel nuts and other bad living habits.
- •5\. The patient has other uncontrolled serious diseases at the same time.
- •6\. Abnormal function of heart, brain, lung and other important organs.
- •7\. Patients who are unable to complete concurrent chemoradiotherapy or delayed treatment for more than 1 week due to subjective factors.
- •8\. The researchers believe that there are any other situations that are not suitable for inclusion.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
A randomized, controlled, multicenter clinical study of theimproved sitting Wuqinxiintervention for mechanically ventilated patients in the intensive care unitRespiratory failureITMCTR2000003360Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Recruiting
Not Applicable
A randomized, controlled, multicenter clinical study of TCM Tuna Gong in the treatment of chronic lower extremity venous insufficiencyITMCTR2024000018Shuguang Hospital, Shanghai University of Traditional Chinese Medicine
Not yet recruiting
Phase 4
A randomized, controlled, multicentre clinical study of Shengu Capsule in the treatment of postmenopausal osteoporosis (deficiency syndrome of liver and kidney)ITMCTR2100004996Fujian Academy of Chinese Medical Sciences
Recruiting
Phase 1
A randomized, controlled, multicentre clinical study of optimizing Yantiao prescription in the treatment of septic shockSeptic shockITMCTR2100004495Shuguang Hospital Affiliated to Shanghai University of Chinese Medicine
Not yet recruiting
Not Applicable
Multiple-center randomized controlled clinical study of electroacupuncture relieving primary dysmenorrheaprimary dysmenorrheaITMCTR2100005394The First Affiliated Hospital ,University of South China